Mounting evidence points to malfunction in Cav-1 as a contributor to endothelial dysfunction in diabetes since increased expression of Cav-1 leads to a reduced EDR by impairing NO bioavailability [65]. The gene discussed is CAV1; the disease is endothelial dysfunction.